Alma M. Rios-Perez
Guadalajara, JAL, Mexico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Antiviral Effect, Safety, and Tolerability of Oral VH4011499 (VH-499), a New HIV-1 Capsid Inhibitor: Proof-of-Concept Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: March 03, 2026
Beyond Protection: The Cytotoxic Effect of Anti-Tat Antibodies in People Living with HIV.
Journal: International journal of molecular sciences
Published: June 19, 2025
Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons.
Journal: The New England journal of medicine
Published: November 27, 2024
Ivermectin compared with placebo in the clinical course in Mexican patients with asymptomatic and mild COVID-19: a randomized clinical trial.
Journal: BMC infectious diseases
Published: May 13, 2022
Genomic instability in people living with HIV.
Journal: Mutation research. Genetic toxicology and environmental mutagenesis
Published: December 28, 2020
Downregulation of SERINC5 expression in buffy coats of HIV-1-infected patients with detectable or undetectable viral load.
Journal: Molecular biology reports
Published: November 23, 2020
MicroRNA-296-5p is differentially expressed in individuals with and without HIV-1 infection.
Journal: Genetics and molecular biology
Published: January 28, 2020
Plasma microRNA expression levels in HIV-1-positive patients receiving antiretroviral therapy.
Journal: Bioscience reports
Published: December 30, 2019
The Mexican consensus on the treatment of hepatitis C.
Journal: Revista de gastroenterologia de Mexico (English)
Published: August 08, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026